Sonoma Pharmaceuticals

(NASDAQ) SNOA

Current Price$1.21

Market Cap$5.79M

Since IPO (2007)-100%

5 Year-99%

1 Year-59%

1 Month+4%

Sonoma Pharmaceuticals Financials at a Glance

Market Cap

$5.79M

Revenue (TTM)

$19.53M

Net Income (TTM)

-$3.18M

EPS (TTM)

-$1.89

P/E Ratio

-0.64

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.21

Volume

60,647.258

Open

$1.22

Price

$1.21

Volume

60,647.258

Open

$1.22

Previous Close

$1.21

Daily Range

$1.19 - $1.23

52-Week Range

$0.85 - $6.92

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$1.21

Volume

60,647.258

Open

$1.22

Previous Close

$1.21

Daily Range

$1.19 - $1.23

52-Week Range

$0.85 - $6.92

Estimated Earnings Date

Aug 6, 2026

SNOA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sonoma Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

259

CEO

Amy M. Trombly

Website

www.sonomapharma.com

Headquarters

Woodstock, GA 30189, US

SNOA Financials

Key Financial Metrics (TTM)

Gross Margin

37.97%

Operating Margin

-12.60%

Net Income Margin

-16.26%

Return on Equity

-88.38%

Return on Capital

-62.51%

Return on Assets

-22.74%

Earnings Yield

-1.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.79M

Shares Outstanding

4.79M

Volume

60.65K

Avg. Volume

238.59K

Financials (TTM)

Gross Profit

$7.42M

Operating Income

-$2.46M

EBITDA

-$2.32M

Operating Cash Flow

-$3.39M

Capital Expenditure

-$229.00K

Free Cash Flow

-$3.62M

Cash & ST Invst.

$2.40M

Total Debt

$842.00K

Sonoma Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$5.56M

+48.1%

Gross Profit

$2.18M

+42.7%

Gross Margin

39.22%

N/A

Market Cap

$5.79M

N/A

Market Cap/Employee

$579.08K

N/A

Employees

N/A

Net Income

-$581.00K

+25.1%

EBITDA

-$318.00K

+49.1%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

$2.40M

-55.4%

Total Debt

$842.00K

+176.1%

Accounts Receivable

$2.53M

-32.8%

Inventory

$3.65M

+25.2%

Long Term Debt

$469.00K

+1637.0%

Short Term Debt

$373.00K

+34.2%

Return on Assets

-22.74%

N/A

Return on Invested Capital

-26.96%

N/A

Free Cash Flow

-$548.00K

-197.3%

Operating Cash Flow

-$519.00K

-191.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.37+2.82%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.08-3.70%

FLGCFlora Growth Corp.

FLGCFlora Growth Corp.$7.79-32.14%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$4.58-2.76%

BFRIBiofrontera Inc.

BFRIBiofrontera Inc.$1.01+0.00%

MYNZMainz Biomed B.V.

MYNZMainz Biomed B.V.$3.59+0.84%

EVOKEvoke Pharma, Inc.

EVOKEvoke Pharma, Inc.$11.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About SNOA

What is the current price of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals is trading at $1.21 per share.

What is the 52-week range for Sonoma Pharmaceuticals?

Over the past 52 weeks, Sonoma Pharmaceuticals has traded between $0.85 and $6.92.

How much debt does Sonoma Pharmaceuticals have?

As of the most recent reporting period, Sonoma Pharmaceuticals reported total debt of $842.00K.

How much cash does Sonoma Pharmaceuticals have on hand?

Sonoma Pharmaceuticals reported $2.40M in cash and cash equivalents in its most recent financial results.

What is Sonoma Pharmaceuticals’s dividend yield?

Sonoma Pharmaceuticals does not currently have a dividend yield.

Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Financials at a Glance

SNOA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sonoma Pharmaceuticals

SNOA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sonoma Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNOA

What is the current price of Sonoma Pharmaceuticals?

What is the 52-week range for Sonoma Pharmaceuticals?

How much debt does Sonoma Pharmaceuticals have?

How much cash does Sonoma Pharmaceuticals have on hand?

What is Sonoma Pharmaceuticals’s dividend yield?

Premium Investing Services